Martin is responsible for the Translational Research Funding line of the Else Kröner Fresenius Foundation (EKFS) in Bad Homburg, Germany, and is currently CEO of the foundation´s non-profit subsidiary ForTra gGmbH für Forschungstransfer. The EKFS Translational Research Funding is aimed to support innovative early-phase biomedical projects with high translational potential, until they reach a sufficient Technology Readiness Level to attract professional investors´ interest for further financing.
Martin studied chemistry and obtained his PhD in biochemistry. During his postdoc time in London at the Imperial Cancer Research Fund he specialized in molecular oncology. He spent almost 20 years in academia research as a group leader at the Georg-Speyer-Haus in Frankfurt/Main, before he joined the EKFS in 2016.